JZJunkang Zhao

Junkang Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Junkang Zhao has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Liyun Zhang

    Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China

    3 shared publications
  • Yangyu Xu

    Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi Province, China

    3 shared publications
  • Hong Zhao

    Rheumatology and Immunology Department, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, Shanxi, China

    2 shared publications
  • Jiannan Han

    Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China

    2 shared publications
  • Jie Kang

    Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China

    2 shared publications
  • Junyan Zhang

    Department of Clinical Epidemiology and Evidence-based Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, 030032, China

    2 shared publications

Latest Publications

  • Open Access

    Comparison analysis of the triglyceride-glucose index, triglyceride-glucose and frailty index in cardiovascular disease and mortality association among patients with rheumatoid arthritis

    by Yangyu Xu, Hong Zhao, Yuxiang Gao, Jiannan Han, Zewen Wu, Liyun Zhang, Junkang Zhao

    Cardiovascular disease (CVD) is a major cause of excess mortality among patients with rheumatoid arthritis (RA). Conventional risk assessment may not fully capture the metabolic abnormalities and physiological vulnerability associated with RA. We investigated whether the triglyceride-glucose–frailty index (TyG-FI), which combines a surrogate marker of insulin resistance with accumulated health deficits, was associated with prevalent CVD and cardiovascular mortality among adults with RA. We analyzed 1090 adults with self-reported RA from 10 cycles of the National Health and Nutrition Examination Survey conducted between 1999 and 2018. TyG-FI was calculated as the product of the triglyceride-glucose index and a 49-item deficit-accumulation frailty index. Multivariable logistic regression was used to examine the association with prevalent CVD, whereas Cox proportional hazards regression was used to examine cardiovascular mortality. Restricted cubic splines, subgroup analyses, sensitivity analyses, and discrimination analyses were conducted as secondary analyses. In the fully adjusted models, each 1-unit higher TyG-FI was associated with higher odds of prevalent CVD (odds ratio, 4.50; 95% confidence interval, 3.20–6.33) and a higher hazard of cardiovascular mortality (hazard ratio, 1.77; 95% confidence interval, 1.16–2.70). The reported areas under the receiver operating characteristic curve were 0.80 for prevalent CVD and 0.81 for cardiovascular mortality in models incorporating TyG-FI, compared with 0.73 and 0.80, respectively, in models incorporating TyG. An exploratory subgroup analysis suggested a stronger association between TyG-FI and prevalent CVD among participants aged ≤65 years ( P for interaction = .044). Higher TyG-FI was associated with prevalent CVD and cardiovascular mortality among US adults with self-reported RA. TyG-FI may capture complementary metabolic and frailty-related information; however, its incremental predictive value, calibration, clinical utility, and external validity require further evaluation before clinical implementation.

  • Open Access

    Research on the correlation between artificial intelligence and depression

    by Chunrong He, Junkang Zhao

    This study aims to systematically assess the research productivity of artificial intelligence (AI) technologies and depression using bibliometric methods, while also exploring the trends and prospects of AI applications in the diagnosis, prediction, and treatment of depression. This study employs bibliometric analysis, using the Web of Science database to collect relevant literature on depression and AI from 2000 to 2024. By analyzing indicators such as changes in the number of publications, keyword co-occurrence, author collaboration networks, and academic impact evaluation, the study comprehensively assesses the research dynamics and key topics in this field. The literature data are analyzed using visualization tools to identify core research themes and future development trends. From 2000 to 2024, the number of studies combining depression and AI showed steady growth. This study identified a total of 1437 papers published in 766 academic journals. Keyword analysis revealed that machine learning, deep learning, natural language processing, chatbots, and neuromorphic computing are the primary technological approaches used in this research. Regarding application domains, publications were categorized into screening (173 articles), diagnosis (279 articles), and treatment (944 articles), with a smaller group covering other aspects (41 articles). Additionally, international collaborative research has increased year by year, with particularly prominent scientific activities observed in the United States, China, and the United Kingdom. AI technology has demonstrated significant potential in the research and application of depression, particularly in precise diagnosis, personalized treatment, and early intervention. Nevertheless, key research gaps persist; long-term efficacy evidence is scarce, lack of standardized validation, and cross-disciplinary integration remains insufficient. This study employs bibliometrics analysis to map the field’s evolution, identifying these critical areas requiring focused research and collaboration to fully harness AI’s potential against depression.

  • Open Access

    Association of eosinophil levels with 30-day overall mortality in hospitalized patients with aspiration pneumonia

    by Xia Jing, Li Li, Junyan Zhang, Haihong Zhao, Jing Li, Jixiu Fan, Jin Huo, Yueqin Li, Junkang Zhao

    Aspiration pneumonia (AP) is expected to have an increasing contribution to morbidity and mortality, particularly in the elderly population over the next coming decades. However, there are no reliable disease evaluation methods and prognostic indicators for patients with AP. A total of 841 patients with AP were included in this single-center prospective cohort study, among which 406 patients were in the eosinopenia group (an absolute eosinophil count < 0.05 × 109/L), and 435 patients were in the non-eosinopenia group (an absolute eosinophil count ≥ 0.05 × 109/L). The primary outcome measure was 30-day overall mortality. The Cox proportional-hazards regression models with overlap weighting according to the propensity score were employed to estimate the associations between eosinopenia level and 30-day overall mortality. 841 AP patients (406 in eosinopenia, 435 in non-eosinopenia), mean ages (75.15 ± 16.76 years in eosinopenia, 78.23 ± 15.28 years in non-eosinopenia), 71 deaths within 30 days (62 in eosinopenia, 9 in non-eosinopenia), 30-day death rates were 15.27% in eosinopenia and 2.07% in non-eosinopenia), 30-day overall mortality hazard ratio by multivariate Cox regression (HR 3.884. for eosinopenia vs. non-eosinopenia, 95% CI 1.772-8.514), after propensity score weighting-overlap weighting (HR 2.337, 95% CI 1.052-5.194), sensitivity analyses ratio (HR 2.951, 95% CI 1.163-7.484) by propensity score matching and (HR 2.574, 95% CI 1.143-5.796) by propensity score regression. The Aspiration Pneumonia Patients with Low Eosinophil counts (APPLE) prospective cohort study suggested that eosinopenia in patients with AP was associated with an increased risk of 30-day overall mortality.Trial registration: Chinese Clinical Trial Registry. URL https://www.chictr.org.cn/. Registration number ChiCTR2300076254. Registration date September 28, 2023.

  • Open Access

    Association between AISI and mortality among individuals with abdominal obesity: A cohort study

    by Qingmei Niu, Junkang Zhao, Yatian Jia, Shuo Ding, Yuxiang Gao, Wenjing Li, Qian Zhang

    This study examines the association between the aggregate index of systemic inflammation (AISI) and mortality among individuals with abdominal obesity, aiming to provide a scientific basis for accurate identification of high-risk individuals and the implementation of early interventions. This study utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999–2016 to include adults with abdominal obesity. The AISI was calculated as (neutrophil count × platelet count × monocyte count)/lymphocyte count. Participants were linked to the National Death Index to determine vital status, with mortality follow-up extending through December 31, 2019. The association between the AISI and mortality risk in individuals with abdominal obesity was examined through Kaplan–Meier survival analysis, weighted Cox proportional hazards regression, subgroup stratification, and restricted cubic spline modeling. This cohort study enrolled 15,839 adult participants with abdominal obesity. During a median follow-up of 119 months, 2223 deaths were recorded. Kaplan–Meier survival analysis showed that elevated levels of the AISI were significantly associated with reduced survival probability. After comprehensive adjustment for multiple potential confounders, multivariate Cox proportional hazards regression revealed a significant positive association between AISI levels and all-cause mortality risk in individuals with abdominal obesity. When AISI was treated as a continuous variable, each 1-unit increase was associated with a 1% higher risk of death (fully adjusted HR = 1.01, 95% CI: 1.01–1.01, P < .001). When dichotomized at the median, the high AISI group exhibited a 16% increased risk of mortality compared to the low AISI group (fully adjusted HR = 1.16, 95% CI: 1.04–1.30, P = .010). Restricted cubic spline analysis confirmed a statistically significant linear relationship ( P for overall < .001; P for nonlinearity = .192). Subgroup analyses indicated heterogeneity in this association across marital status subgroups (interaction P = .017). This study demonstrates that elevated AISI levels are associated with increased mortality risk among individuals with abdominal obesity. These findings underscore the value of AISI as a prognostic indicator for mortality in this at-risk population. The integration of AISI into clinical inflammatory assessment frameworks may facilitate the establishment of dynamic surveillance strategies for identifying and monitoring high-risk individuals.


  • Open Access

    Association Between Neutrophil Percentage–Albumin Ratio and Biological Aging in Rheumatoid Arthritis in the United States: A Cross‐Sectional Study of NHANES

    by Yangyu Xu, Hong Zhao, Yuxiang Gao, Li Zhao, Jiannan Han, Rong Li, Zewen Wu, Junkang Zhao, Liyun Zhang

    Background: The accelerating process of global aging has made the burden of age‐related diseases increasingly severe, and traditional chronological age fails to reflect individual heterogeneity in aging. The neutrophil percentage‐to‐albumin ratio (NPAR), is a multidimensional health assessment index composed of inflammatory markers (neutrophils) and nutritional markers (albumin) to reflect inflammation and nutritional status, has shown unique potential in rheumatoid arthritis (RA) research. However, its association with biological age (BA; such as Klemera–Doubal method [KDM] age and phenotypic age, PhenoAge) has not yet been systematically validated in RA patients. By evaluating NPAR indicators in patients with RA, this study intends to reveal its value as a potential biomarker for predicting biological aging and its acceleration. Methods: This study was based on the National Health and Nutrition Survey 1999–2018 cycle database, and a cross‐sectional analysis of 1053 adult patients with RA was included. Core variable definitions include: neutrophil–albumin ratio (NPAR) = percentage of neutrophils (%)/albumin (g/dL); BA was calculated by the KDM (including 10 biomarkers) and the PhenoAge algorithm, respectively. Accelerated aging is quantified as the difference between BA and chronological age. The statistical analysis used a multi‐model validation strategy: 1) multivariate linear regression to evaluate the association between NPAR and continuous aging acceleration indicators; 2) the restricted cubic spline (RCS) model explores the nonlinear relationship; 3) stratified subgroup analysis to test for effect heterogeneity. All models were stratified for sociodemographic characteristics (age, sex, and ethnicity), lifestyle factors (smoking, alcohol consumption, and physical activity), and clinical covariates (body mass index [BMI], hypertension, and history of diabetes). Results: In an analysis of 1053 RA patients in the United States, women accounted for 56.48% and men for 43.52%; the group with the highest NPAR (T3) showed more significant aging characteristics (≥65 years old 34.75%, females 62.80%, and diabetes 27.69%) and higher biological aging acceleration rates (KDM acceleration 42.81% vs. low group 25.81%; PhenoAge acceleration 62.13% vs. 37.74%; all p < 0.001). After adjustment for multiple factors, the BA of KDM increased by 0.86 years for every 1 unit increase in NPAR (95% confidence interval [CI]: 0.39–1.32, p < 0.001), and PhenoAge increased by 1.32 years (95% CI: 0.93–1.71, p < 0.001). Taking the lowest NPAR group (T1) as the reference group, the highest NPAR group (T3) had an increased risk of accelerated aging of KDM by 149% (OR = 2.49, 95% CI: 1.44–4.31), and the risk of PhenoAge increased sharply by 259% (OR = 3.59, 95% CI: 2.17–5.95). Nonrestrictive spline curve analysis further revealed that there was a nonlinear positive correlation between the NPAR index and biological aging. When NPAR > 13.128, the growth rate of biological aging was significantly accelerated ( p for nonlinear = 0.05), while when NPAR > 14.512, the risk of phenotypic aging accelerated sharply ( p for nonlinear = 0.002). Area under the curve (AUC) of NPAR in the combined model for predicting biological senescence acceleration was 0.71–0.75. Discussion: Elevated NPAR is significantly associated with accelerated biological aging in RA patients, and the mechanism may involve neutrophil migration dysfunction, oxidative damage caused by albumin deficiency, and chronic inflammatory pathways (such as NF‐ κ B activation). As a low‐cost inflammatory marker, NPAR holds promise for integration into clinical aging risk assessment systems to identify high‐risk RA populations requiring early intervention. The study’s limitations include the inability to infer causality due to the cross‐sectional design and a relatively small sample size, necessitating further validation through cohort studies in the future.


  • Open Access

    Investigating the Impact of Gut Microbiota and Immune Cells on Ankylosing Spondylitis From a Genetic Perspective: A Mendelian Randomization and Mediation Study

    by Jiannan Han, Jingying Wu, Hong Zhao, Yangyu Xu, Yuxiang Gao, Jie Kang, Junkang Zhao, Liyun Zhang

    Background: Previous studies have separately reported causal relationships between gut microbiota and ankylosing spondylitis (AS), as well as between immune cells and AS. However, the potential causal relationships between gut microbiota/immune cells and AS have not been explored. In this study, we elucidated the role of gut microbiota in the progression of AS through the regulation of immune cells. Methods: Inverse‐variance weighted (IVW) was used as the primary analysis method, supplemented by MR‒Egger, simple mode, weighted median, and weighted mode methods to determine the causal relationships between gut microbiota and AS. Additionally, Bayesian weighted Mendelian randomization (BWMR) was used to identify the strongest causal associations, and mediation MR analysis was performed to explore the potential mediating role of immune cells in the relationship between gut microbiota and AS. Results: MR analysis identified 13 microbial taxa significantly associated with AS, of which eight were significantly associated with an increased risk of AS. Additionally, five microbial taxa were significantly associated with a reduced risk of AS. Furthermore, 19 immunophenotypes were significantly associated with AS, of which 11 were linked to an increased risk of AS. Additionally, eight immune cells were associated with a reduced risk of AS. Mediation MR analysis revealed that two immune cells mediated the causal relationships of two gut microbiota: CX3CR1 on monocyte mediated a 7.91% increase in AS risk through the CAG‐83 sp000435555 abundance in stool pathway, and CD45 on CD33 − HLA DR − mediated a 12.04% increase in AS risk through the Clostridium S felsineum abundance in stool pathway. Multiple sensitivity analyses confirmed the robustness of our results. Conclusion: This study is the first to reveal the causal relationships among gut microbiota, immune cells, and AS. These findings provide genetic evidence supporting a potential causal role of gut microbiota in AS, suggesting that immune cells may act as mediators.

  • Open Access

    The Role of Inflammatory Cytokines in the Causal Pathway From Gut Microbiota to Sjögren’s Syndrome: Evidence From Mendelian Randomization

    by Junkang Zhao, Jiannan Han, Xiuying Fan, Jie Kang, Ruonan Wu, Yixuan Zhao, Lina Bai, Xue Gao, Dan Ma, Liyun Zhang

    Purpose: Evidence is accumulating that links gut microbiota, a crucial component of the immune environment, to Sjogren’s syndrome (SS). The mechanisms underlying the influence of gut microbiota on the onset and development of SS are still not completely understood. To this end, we applied a Mendelian randomization (MR) framework to investigate whether inflammatory cytokines mediate the association of gut microbiota with SS. Methods: Our MR analysis leveraged publicly available GWAS data, including information on 211 gut microbiota taxa sourced from the MiBioGen consortium (18,340 participants), summary statistics for 91 inflammatory cytokines obtained from a study of 14,824 individuals, and genetic data for SS derived from the UK Biobank (407,746 participants). To investigate causal associations between gut microbiota and SS, we primarily employed the inverse variance weighted method, supported by additional techniques such as MR‐Egger, simple mode, weighted median, and weighted mode for validation. The potential mediating effect of inflammatory cytokines in the gut microbiota–SS relationship was investigated using both mediation MR and multivariable MR (MVMR) analyses. Results: MR analysis identified five microbiota taxa causally associated with SS. Particularly, class Gammaproteobacteria (OR = 3.468, 95% CI = 1.139–10.557, p = 0.029) and genus Peptococcus (OR = 1.722, 95% CI = 1.082–2.471, p = 0.022) were significantly associated with an increased risk of developing SS. Six inflammatory cytokines were identified as potentially causal, with Axin‐1 (OR = 2.556, 95% CI = 1.072–6.096, p = 0.034) and C‐X‐C motif chemokine 10 levels (CXCL10) (OR = 3.049, 95% CI = 1.428–6.513, p = 0.004) being the most critical contributors. Mediation MR analysis showed that Axin‐1 levels mediated 16.96% of the causal effect of class Gammaproteobacteria on SS, CXCL10 levels mediated 36.78% of the causal effect of genus Coprococcus3 on SS. Conclusion: The findings suggest that certain gut microbiota is sociated with an increased risk of SS, mediated by specific inflammatory cytokines.


  • Open Access

    Trajectories of plant-based diet indices and the associated risk of hypertension among Chinese adults: a cohort study based on the China Health and Nutrition Survey 2004–2015

    by Yajie Zhao, Qian Gao, Junyan Zhang, Juping Wang, Tetsuya Araki, Junkang Zhao

    Plant-based diets have been found to be associated with hypertension. Dietary intake is a dynamic and changing process that can be better characterized by trajectories of dietary indices. However, the associations between plant-based diet trajectories and hypertension over time remained unknown. We used data from the China Health and Nutrition Survey 2004–2015 to analyze a cohort of Chinese adults ≥ 18 years of age who had no hypertension at baseline. Plant-based diets were measured by an overall plant-based diet index (PDI), healthful plant-based diet index (hPDI), and unhealthful plant-based diet index (uPDI) based on three 24-hour recalls. Trajectories of PDI, hPDI, and uPDI (2004 to 2011) were identified using group-based trajectory modeling. The associations between trajectories of PDIs and the risk of new-onset hypertension were estimated using Cox proportional hazard models. We identified three trajectories for PDI, two for hPDI, and four for uPDI among the 2853 participants with a mean follow-up of 9.6 years. Compared with the PDI “low and stable” class, the PDI “high and decreasing” class had a 23% decreased risk (HR: 0.77; 95% CI: 0.62–0.95) of hypertension. There was no significant association with PDI “low and increasing” class. Compared with the hPDI “low and stable” class, the hPDI “high and stable” class had a 24% decreased risk (HR: 0.76; 95%CI: 0.64–0.91). For uPDI trajectories, compared with the “low and decreasing” class, the “high and increasing,” “high and stable,” and “low and increasing” classes had increased risks of 43% (HR: 1.43; 95% CI: 1.06–1.94), 77% (HR: 1.77; 95% CI: 1.26–2.49), and 72% (HR: 1.72; 95% CI: 1.26–2.33), respectively. This study underscores the importance of maintaining high intakes of healthful plant-based diets and low intakes of unhealthful plant-based diets overtime for hypertension prevention.